Keyphrases
Anaplasma Phagocytophilum
66%
Anaplasmosis
100%
Babesia Infection
13%
Babesiosis
66%
Clinical Diagnosis
66%
Clinical Features
66%
Clinical Outcomes
66%
Confidence Interval
44%
Corticosteroid Therapy
11%
Corticosteroid Treatment
33%
Corticosteroids
44%
COVID-19
66%
Days of Treatment
22%
Disease Severity
22%
Emerging Infections
16%
Health Departments
16%
Immune Response
33%
Medical Center
66%
Medical Education
33%
Meta-analysis
66%
Mortality Benefit
11%
Optimal Duration
66%
Penn State
33%
Pennsylvania
66%
Pooled Analysis
11%
Principal Investigator
33%
Protective Association
11%
Random-effects Meta-analysis
11%
Randomized Controlled Trial
11%
Risk Ratio
33%
School of Medicine
33%
State Colleges
33%
Subgroup Analysis
11%
Survival Benefit
66%
Symptom Duration
22%
Systematic Meta-analysis
66%
Systemic Corticosteroids
66%
Tick-borne Diseases
33%
Treatment Duration
11%
Treatment Risk
11%
United States
16%
Western Pennsylvania
16%
Medicine and Dentistry
Anaplasmosis
100%
Awareness
16%
Babesia
22%
Babesiosis
66%
Clinical Feature
66%
Clinician
16%
Corticosteroid
66%
Corticosteroid Therapy
44%
COVID-19
66%
Diseases
22%
Hope
16%
Human Granulocytic Anaplasmosis
66%
Immune Response
33%
Infection
50%
Medicine
33%
Meta-Analysis
66%
Observational Study
11%
Pooled Analysis
11%
Randomized Controlled Trial
11%
Subgroup Analysis
11%
Systematic Review
66%
Tick-Borne Disease
33%
Treatment Duration
11%